Retatrutide, the triple agonist targeting GLP-1, GIP, and glucagon receptors, shows approximately 24% weight loss in phase 2 trials
But glucagon receptor activation also stimulates energy expenditure and fat oxidation in the liver
Current senolytic agents are primarily employed in cancer therapies, such as doxorubicin, trametinib, and cell cycle-targeting drugs like palbociclib (Lea et al., 2022
Don't wipe it with something else
Expecting reasonable, gradual progress rather than immediate transformation leads to better adherence and more sustainable results
"BPC 157 and angiogenesis: The potential of promoting new blood vessel formation in injury repair." Annals of Anatomy , 196(6), 376383